All In MedTech

Device Trial Radar · NCT03385187

Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Last checked: Nov 19, 2026Latest source record: Mar 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

450

Planned (sponsor's estimate)

Start

Jun 29, 2017

Primary completion

Sep 15, 2019

Study completion Dec 15, 2019

Sponsor

Lead sponsor
Ectosense NVNot on our public-company list
Sponsor type
Industry
Collaborators
Ziekenhuis Oost-Limburg
First posted
Dec 28, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Prospective validation study of the NightOwl, a Type IV home sleep apnea test (HSAT), compared to a traditional Type I and a Type IV sleep monitor.

Conditions

  • Sleep Apnea

Interventions

  • NightOwl HSATDevice

    Patient wears the NightOwl sensor device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Apnea-Hypopnea Index (AHI)Time frame: At the time of the diagnostic night

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ziekenhuis Oost-Limburg

    Genk, Limburg, Belgium · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.